Waters Buffeted by Receding Sales As High-End Tool Sector Takes a Hit | GenomeWeb

Prompted by a poor outlook in the European drug sector, Baird analyst Larry Neibor last week downgraded Waters' stock after the company cut its first-quarter revenue and earnings projections — and then promptly downgraded his entire analytical instruments sector, which includes BioCommerce Week Index members Applied Biosystems, Bruker BioSciences, Molecular Devices, PerkinElmer, Thermo Electron, and Waters

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: genes involved in histone deacetylation in Arabidopsis, effects of pathogenic presenilin-1 mutations, and more.

After a study finds DNA from antibiotic-resistant bacteria in Beijing smog, residents there worry, according to the New York Times.

Canada begins its search for a chief government science advisor, Nature News reports.

A company is using facial recognition tools to identify genetic disorders from pictures, Technology Review reports.